In 2008, the Azelis Group acquired Marigold International Pvt. Ltd, an Indian distributor of polymers and chemicals based in Mumbai. This represented the beginning of Azelis India and it allowed us not only to serve the local markets but also to offer European manufacturers a route to market in the Indian economy. With the acquisition of S&D Chemicals (Pharma API business) in 2011, Azelis established fully-fledged operations in the country. Since then Azelis India has expanded into other segments such as Coatings, Homecare & Industrial Cleaning, Food & Nutrition and Personal Care, representing many global companies active in these segments. More recently, we have strengthened our organization by establishing a number of warehouses and application labs. We have also put in place a highly knowledgeable team of regulatory professionals, in India, that cater to our regulatory needs on a global basis.

The acquisition of Chemo India and Unipharm Laboratories’ distribution assets in 2022 strengthened Azelis India's industrial chemicals portfolio and its footprint in the pharmaceutical market, further reinforcing its lateral value chain (LVC) for these market segments. 

Also in 2022, the acquisition of a majority stake in Ashapura Aromas Private Limited, a leading distributor of ingredients in the flavors & fragrances market in India, provided Azelis with a strong F&F platform in Asia Pacific.

For the Pharma & Healthcare market segment, Azelis India also services customers in Sri Lanka and Bangladesh.

General terms & conditions of sale